HEADER TRANSFERASE 15-NOV-02 1N7J TITLE THE STRUCTURE OF PHENYLETHANOLAMINE N-METHYLTRANSFERASE IN COMPLEX TITLE 2 WITH S-ADENOSYLHOMOCYSTEINE AND AN IODINATED INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHENYLETHANOLAMINE N-METHYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PNMTASE, NORADRENALINE N-METHYLTRANSFERASE; COMPND 5 EC: 2.1.1.28; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PNMT OR PENT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET17 KEYWDS METHYLTRANSFERASE, CATECHOLAMINE, ADRENALINE, EPINEPHRINE, S- KEYWDS 2 ADENOSYLMETHIONINE, S-ADENOLSYLHOMOCYSTEINE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR F.M.MCMILLAN,J.ARCHBOLD,M.J.MCLEISH,J.M.CAINE,K.R.CRISCIONE, AUTHOR 2 G.L.GRUNEWALD,J.L.MARTIN REVDAT 4 14-FEB-24 1N7J 1 REMARK REVDAT 3 24-FEB-09 1N7J 1 VERSN REVDAT 2 24-FEB-04 1N7J 1 JRNL REVDAT 1 23-DEC-03 1N7J 0 JRNL AUTH F.M.MCMILLAN,J.ARCHBOLD,M.J.MCLEISH,J.M.CAINE,K.R.CRISCIONE, JRNL AUTH 2 G.L.GRUNEWALD,J.L.MARTIN JRNL TITL MOLECULAR RECOGNITION OF SUB-MICROMOLAR INHIBITORS BY THE JRNL TITL 2 EPINEPHRINE-SYNTHESIZING ENZYME PHENYLETHANOLAMINE JRNL TITL 3 N-METHYLTRANSFERASE. JRNL REF J.MED.CHEM. V. 47 37 2004 JRNL REFN ISSN 0022-2623 JRNL PMID 14695818 JRNL DOI 10.1021/JM0205752 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.39 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1521446.240 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.4 REMARK 3 NUMBER OF REFLECTIONS : 22075 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.232 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2192 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 81.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2861 REMARK 3 BIN R VALUE (WORKING SET) : 0.3750 REMARK 3 BIN FREE R VALUE : 0.4020 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 333 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.022 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4065 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 56 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.77000 REMARK 3 B22 (A**2) : 4.77000 REMARK 3 B33 (A**2) : -9.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM SIGMAA (A) : 0.60 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.45 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.71 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.240 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.200 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.720 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.720 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.29 REMARK 3 BSOL : 18.39 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : IODO_JLM.PAR REMARK 3 PARAMETER FILE 4 : SAH_MOD2.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : IODO.TOP REMARK 3 TOPOLOGY FILE 4 : SAH_MOD.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1N7J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-DEC-02. REMARK 100 THE DEPOSITION ID IS D_1000017616. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JUL-97 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NICKEL FILTER REMARK 200 OPTICS : YALE MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22078 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 31.390 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.3 REMARK 200 DATA REDUNDANCY : 2.360 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.27900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIFFERENCE FOURIER REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1HNN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6K, LITHIUM CHLORIDE, CACODYLATE , REMARK 280 PH 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 93.45000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 47.37000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 47.37000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 140.17500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 47.37000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 47.37000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 46.72500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 47.37000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.37000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 140.17500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 47.37000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.37000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 46.72500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 93.45000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 465 ALA A 4 REMARK 465 ASP A 5 REMARK 465 ARG A 6 REMARK 465 SER A 7 REMARK 465 PRO A 8 REMARK 465 ASN A 9 REMARK 465 ALA A 10 REMARK 465 GLY A 11 REMARK 465 ALA A 12 REMARK 465 ALA A 13 REMARK 465 PRO A 14 REMARK 465 ASP A 15 REMARK 465 SER A 16 REMARK 465 ALA A 17 REMARK 465 PRO A 18 REMARK 465 GLY A 19 REMARK 465 GLN A 20 REMARK 465 ALA A 21 REMARK 465 MET B 501 REMARK 465 SER B 502 REMARK 465 GLY B 503 REMARK 465 ALA B 504 REMARK 465 ASP B 505 REMARK 465 ARG B 506 REMARK 465 SER B 507 REMARK 465 PRO B 508 REMARK 465 ASN B 509 REMARK 465 ALA B 510 REMARK 465 GLY B 511 REMARK 465 ALA B 512 REMARK 465 ALA B 513 REMARK 465 GLY B 781 REMARK 465 LEU B 782 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 29 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 33 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 108 CG CD OE1 NE2 REMARK 470 LYS A 136 CG CD CE NZ REMARK 470 GLN A 163 CG CD OE1 NE2 REMARK 470 LEU A 165 CG CD1 CD2 REMARK 470 SER A 169 OG REMARK 470 GLU A 241 CG CD OE1 OE2 REMARK 470 ARG A 245 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 529 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 573 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 737 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 49 102.58 103.86 REMARK 500 ASP A 101 132.72 167.00 REMARK 500 PRO A 164 99.89 -26.57 REMARK 500 LEU A 165 51.12 13.91 REMARK 500 CYS A 183 -83.83 -104.50 REMARK 500 ALA A 224 62.80 -163.50 REMARK 500 VAL A 250 104.28 -57.96 REMARK 500 ASP A 267 -172.62 -175.83 REMARK 500 LYS A 279 96.87 -68.34 REMARK 500 SER B 592 36.14 -81.09 REMARK 500 HIS B 593 -15.61 -145.23 REMARK 500 ALA B 620 151.78 -46.90 REMARK 500 ARG B 653 142.65 162.93 REMARK 500 CYS B 683 -73.21 -101.94 REMARK 500 VAL B 687 -8.55 -142.76 REMARK 500 ASP B 767 -176.22 -172.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH A 2002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH B 2003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IDI B 3002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IDI A 3003 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HNN RELATED DB: PDB DBREF 1N7J A 1 282 UNP P11086 PNMT_HUMAN 1 282 DBREF 1N7J B 501 782 UNP P11086 PNMT_HUMAN 1 282 SEQRES 1 A 282 MET SER GLY ALA ASP ARG SER PRO ASN ALA GLY ALA ALA SEQRES 2 A 282 PRO ASP SER ALA PRO GLY GLN ALA ALA VAL ALA SER ALA SEQRES 3 A 282 TYR GLN ARG PHE GLU PRO ARG ALA TYR LEU ARG ASN ASN SEQRES 4 A 282 TYR ALA PRO PRO ARG GLY ASP LEU CYS ASN PRO ASN GLY SEQRES 5 A 282 VAL GLY PRO TRP LYS LEU ARG CYS LEU ALA GLN THR PHE SEQRES 6 A 282 ALA THR GLY GLU VAL SER GLY ARG THR LEU ILE ASP ILE SEQRES 7 A 282 GLY SER GLY PRO THR VAL TYR GLN LEU LEU SER ALA CYS SEQRES 8 A 282 SER HIS PHE GLU ASP ILE THR MET THR ASP PHE LEU GLU SEQRES 9 A 282 VAL ASN ARG GLN GLU LEU GLY ARG TRP LEU GLN GLU GLU SEQRES 10 A 282 PRO GLY ALA PHE ASN TRP SER MET TYR SER GLN HIS ALA SEQRES 11 A 282 CYS LEU ILE GLU GLY LYS GLY GLU CYS TRP GLN ASP LYS SEQRES 12 A 282 GLU ARG GLN LEU ARG ALA ARG VAL LYS ARG VAL LEU PRO SEQRES 13 A 282 ILE ASP VAL HIS GLN PRO GLN PRO LEU GLY ALA GLY SER SEQRES 14 A 282 PRO ALA PRO LEU PRO ALA ASP ALA LEU VAL SER ALA PHE SEQRES 15 A 282 CYS LEU GLU ALA VAL SER PRO ASP LEU ALA SER PHE GLN SEQRES 16 A 282 ARG ALA LEU ASP HIS ILE THR THR LEU LEU ARG PRO GLY SEQRES 17 A 282 GLY HIS LEU LEU LEU ILE GLY ALA LEU GLU GLU SER TRP SEQRES 18 A 282 TYR LEU ALA GLY GLU ALA ARG LEU THR VAL VAL PRO VAL SEQRES 19 A 282 SER GLU GLU GLU VAL ARG GLU ALA LEU VAL ARG SER GLY SEQRES 20 A 282 TYR LYS VAL ARG ASP LEU ARG THR TYR ILE MET PRO ALA SEQRES 21 A 282 HIS LEU GLN THR GLY VAL ASP ASP VAL LYS GLY VAL PHE SEQRES 22 A 282 PHE ALA TRP ALA GLN LYS VAL GLY LEU SEQRES 1 B 282 MET SER GLY ALA ASP ARG SER PRO ASN ALA GLY ALA ALA SEQRES 2 B 282 PRO ASP SER ALA PRO GLY GLN ALA ALA VAL ALA SER ALA SEQRES 3 B 282 TYR GLN ARG PHE GLU PRO ARG ALA TYR LEU ARG ASN ASN SEQRES 4 B 282 TYR ALA PRO PRO ARG GLY ASP LEU CYS ASN PRO ASN GLY SEQRES 5 B 282 VAL GLY PRO TRP LYS LEU ARG CYS LEU ALA GLN THR PHE SEQRES 6 B 282 ALA THR GLY GLU VAL SER GLY ARG THR LEU ILE ASP ILE SEQRES 7 B 282 GLY SER GLY PRO THR VAL TYR GLN LEU LEU SER ALA CYS SEQRES 8 B 282 SER HIS PHE GLU ASP ILE THR MET THR ASP PHE LEU GLU SEQRES 9 B 282 VAL ASN ARG GLN GLU LEU GLY ARG TRP LEU GLN GLU GLU SEQRES 10 B 282 PRO GLY ALA PHE ASN TRP SER MET TYR SER GLN HIS ALA SEQRES 11 B 282 CYS LEU ILE GLU GLY LYS GLY GLU CYS TRP GLN ASP LYS SEQRES 12 B 282 GLU ARG GLN LEU ARG ALA ARG VAL LYS ARG VAL LEU PRO SEQRES 13 B 282 ILE ASP VAL HIS GLN PRO GLN PRO LEU GLY ALA GLY SER SEQRES 14 B 282 PRO ALA PRO LEU PRO ALA ASP ALA LEU VAL SER ALA PHE SEQRES 15 B 282 CYS LEU GLU ALA VAL SER PRO ASP LEU ALA SER PHE GLN SEQRES 16 B 282 ARG ALA LEU ASP HIS ILE THR THR LEU LEU ARG PRO GLY SEQRES 17 B 282 GLY HIS LEU LEU LEU ILE GLY ALA LEU GLU GLU SER TRP SEQRES 18 B 282 TYR LEU ALA GLY GLU ALA ARG LEU THR VAL VAL PRO VAL SEQRES 19 B 282 SER GLU GLU GLU VAL ARG GLU ALA LEU VAL ARG SER GLY SEQRES 20 B 282 TYR LYS VAL ARG ASP LEU ARG THR TYR ILE MET PRO ALA SEQRES 21 B 282 HIS LEU GLN THR GLY VAL ASP ASP VAL LYS GLY VAL PHE SEQRES 22 B 282 PHE ALA TRP ALA GLN LYS VAL GLY LEU HET SAH A2002 26 HET IDI A3003 11 HET SAH B2003 26 HET IDI B3002 11 HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE HETNAM IDI 7-IODO-1,2,3,4-TETRAHYDRO-ISOQUINOLINE FORMUL 3 SAH 2(C14 H20 N6 O5 S) FORMUL 4 IDI 2(C9 H10 I N) FORMUL 7 HOH *56(H2 O) HELIX 1 1 ALA A 22 TYR A 27 1 6 HELIX 2 2 ALA A 34 TYR A 40 1 7 HELIX 3 3 GLY A 52 THR A 67 1 16 HELIX 4 4 VAL A 84 LEU A 88 5 5 HELIX 5 5 SER A 89 PHE A 94 5 6 HELIX 6 6 GLU A 109 GLN A 115 1 7 HELIX 7 7 TRP A 123 GLY A 135 1 13 HELIX 8 8 CYS A 139 ARG A 150 1 12 HELIX 9 9 CYS A 183 SER A 188 1 6 HELIX 10 10 ASP A 190 THR A 203 1 14 HELIX 11 11 SER A 235 ARG A 240 1 6 HELIX 12 12 ALA A 242 VAL A 244 5 3 HELIX 13 13 SER B 516 GLN B 528 1 13 HELIX 14 14 GLU B 531 ALA B 541 1 11 HELIX 15 15 GLY B 552 THR B 567 1 16 HELIX 16 16 VAL B 584 LEU B 588 5 5 HELIX 17 17 SER B 589 SER B 592 5 4 HELIX 18 18 LEU B 603 GLN B 615 1 13 HELIX 19 19 TRP B 623 GLY B 635 1 13 HELIX 20 20 CYS B 639 ARG B 650 1 12 HELIX 21 21 CYS B 683 VAL B 687 5 5 HELIX 22 22 ASP B 690 THR B 703 1 14 HELIX 23 23 GLU B 738 SER B 746 1 9 HELIX 24 24 PRO B 759 GLN B 763 5 5 SHEET 1 A 7 VAL A 151 LEU A 155 0 SHEET 2 A 7 ASP A 96 THR A 100 1 N MET A 99 O LEU A 155 SHEET 3 A 7 THR A 74 ILE A 78 1 N ASP A 77 O THR A 98 SHEET 4 A 7 ALA A 175 ALA A 181 1 O VAL A 179 N ILE A 78 SHEET 5 A 7 LEU A 205 LEU A 217 1 O ILE A 214 N SER A 180 SHEET 6 A 7 GLY A 271 LYS A 279 -1 O ALA A 277 N LEU A 211 SHEET 7 A 7 TYR A 248 ILE A 257 -1 N ASP A 252 O TRP A 276 SHEET 1 B 2 TRP A 221 ALA A 224 0 SHEET 2 B 2 ALA A 227 THR A 230 -1 O LEU A 229 N TYR A 222 SHEET 1 C 7 VAL B 651 PRO B 656 0 SHEET 2 C 7 PHE B 594 ASP B 601 1 N MET B 599 O LEU B 655 SHEET 3 C 7 GLY B 572 ASP B 577 1 N ASP B 577 O THR B 598 SHEET 4 C 7 ALA B 675 ALA B 681 1 O VAL B 679 N ILE B 576 SHEET 5 C 7 LEU B 705 LEU B 717 1 O LEU B 712 N SER B 680 SHEET 6 C 7 GLY B 771 LYS B 779 -1 O GLY B 771 N LEU B 717 SHEET 7 C 7 TYR B 748 TYR B 756 -1 N ASP B 752 O TRP B 776 SHEET 1 D 2 TRP B 721 LEU B 723 0 SHEET 2 D 2 ARG B 728 THR B 730 -1 O LEU B 729 N TYR B 722 CISPEP 1 PRO A 42 PRO A 43 0 0.58 CISPEP 2 LEU A 173 PRO A 174 0 -0.19 CISPEP 3 PRO B 542 PRO B 543 0 0.23 CISPEP 4 LEU B 673 PRO B 674 0 -0.12 SITE 1 AC1 20 TYR A 27 TYR A 35 TYR A 40 GLY A 79 SITE 2 AC1 20 SER A 80 GLY A 81 THR A 83 TYR A 85 SITE 3 AC1 20 ASP A 101 PHE A 102 LEU A 103 ASN A 106 SITE 4 AC1 20 ILE A 157 ASP A 158 VAL A 159 HIS A 160 SITE 5 AC1 20 ALA A 181 PHE A 182 CYS A 183 VAL A 187 SITE 1 AC2 19 TYR B 527 TYR B 535 TYR B 540 GLY B 579 SITE 2 AC2 19 SER B 580 GLY B 581 THR B 583 TYR B 585 SITE 3 AC2 19 ASP B 601 PHE B 602 LEU B 603 ASN B 606 SITE 4 AC2 19 ILE B 657 ASP B 658 VAL B 659 ALA B 681 SITE 5 AC2 19 PHE B 682 CYS B 683 VAL B 687 SITE 1 AC3 8 TYR B 535 ASN B 539 TYR B 540 PHE B 682 SITE 2 AC3 8 GLU B 719 TYR B 722 MET B 758 ASP B 767 SITE 1 AC4 8 TYR A 35 ARG A 44 PHE A 182 GLU A 219 SITE 2 AC4 8 TYR A 222 MET A 258 ASP A 267 HOH A1052 CRYST1 94.740 94.740 186.900 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010555 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010555 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005350 0.00000